# Major concerns 1. Because of the lack of gold standard for DIC diagnosis, the authors choose '28-days mortality' as an alternative. However, in the most clinical situation, most critically ill patients expired due to the primary underlying cause such as sepsis, multiple trauma or terminal cancer, and DIC accompanies as a secondary complication.
1) If the authors want to compare the DIC scoring systems, the primary underlying condition should be considered and statistically adjusted. Please provide the detailed strategy for this analysis. 2) Furthermore, why the authors select 28-days for the evaluation time point? Please provide the more detailed reason in the manuscript.
2. DIC is a dynamic and rapid process that affect the coagulation parameters. Therefore, global coagulation parameters can be widely fluctuated depending on the ordering time point or the presence of clinical intervention (e.g. transfusion, AT III therapy) which means DIC score can vary in the evaluation time point. For example, if a physician suspects of DIC in the early stage and calculates DIC score, it may present low score. Conversely, if the blood was taken in the severe terminal stage, it may present high score. 1) Do you have a correction plan for this bias in the metaanalysis? 2) Furthermore, will you include the laboratory findings only tested on the same day or will you set a specific inclusion period for laboratory results?
3. The authors selected 6 DIC scoring systems (ISTH overt, nonovert, JMHW, JAAM, KSTH, and CDSS) to evaluate their prognostic value. However, one of the difficult things to compare DIC scoring systems is the lack of standardization for fibrin-related markers and their tests. An identical sample can present different values (e.g. report ranges, report units) for fibrin-related markers depending on the analysis principles or analyzers. This is why ISTH scoring systems use the term 'strong and moderate' increase for their criteria.
1) For pooling the data and comparison, how will the authors define the cut-off values for 'strong and moderate increase' or adjust their different cut-off values? 2) Please provide more description for the analysis strategy in this heterogeneity of the laboratory tests.
4. Based on the raised questions above, DIC scoring systems include difficult characteristics for meta-analysis to compare their diagnostic or prognostic value. I wonder that making a conclusion which DIC criteria are superior for predicting mortality can lead to very dangerous and biased results. Although the attempt to provide a meta-analysis for the prognostic value of DIC scoring systems is a valuable work, the conclusion should not be biased and over-emphasized.
# Minor concerns 1. PRISMA statement Support I cannot find any related information for support on P17.
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GENERAL COMMENTS
The main purpose of this study is to determine which DIC score is better to predict the accuracy of 28 day mortality in critical ill patients. The secondary purpose was to observe the accuracy of different DIC scores in predicting the prognosis of sepsis.
Major comments The etiology of DIC is different, sepsis, trauma, hematological malignancies, hepatic failure, etc. Different DIC scores were used to evaluate the different types of coagulation caused by different diseases. For example, JAAM score was generally used for sepsis.
The biggest issue of this study is the selection bias. For example, more research on sepsis enrolled in the meta analysis might increase the accuracy of JAAM score. Because of the heterogeneity of the critical illness, the secondary objective of the study, it is not recommended that "the accuracy of different DIC scores in predicting 28-day mortality in critical ill patients" should be considered as the primary objective of the study. It is suggested that the primary purpose of this paper is "sepsis". If possible, subgroup analysis should be performed for trauma patients.
VERSION 1 -AUTHOR RESPONSE
Response to reviewer #1
In this protocol, Jumpei et al. target several DIC scoring systems to evaluate their prognostic accuracy for 28-days mortality in critically ill patients by systematic review and meta-analysis. Although the attempt to provide a systematic review and meta-analysis for the prognostic value of DIC scoring systems is a valuable work and the manuscript is meticulously written, there are several major concerns in this study design.
1) If the authors want to compare the DIC scoring systems, the primary underlying condition should be considered and statistically adjusted. Please provide the detailed strategy for this analysis.
Reply
According to the reviewer's comments, we revised the following sentence in the Methods section.
(Lines 224-228)
Meta-regression analysis and subgroup analysis will be performed using the following as covariates: sepsis or not, trauma or not, year of publication, country, prevalence of DIC (<50% or ≥50%), baseline mortality risk, sample size (<100 or ≥100), types of fibrin-related markers, and cut-off values of fibrinrelated markers.
2) Furthermore, why the authors select 28-days for the evaluation time point? Please provide the more detailed reason in the manuscript.
Thank you for your important comments and question. Twenty-eight-day mortality is the standard outcome measure in critical illness settings, and an expected study with a high possibility of being included in this review would likely use 28-day mortality as an outcome. Thus, we will analyse 28-day mortality. According to the reviewer's question, we revised the following sentence in the Methods section.
(Lines 129-130)
The reference standard will be 28-day mortality, which is one of the standard outcome measures in critical care settings.
2. DIC is a dynamic and rapid process that affect the coagulation parameters. Therefore, global coagulation parameters can be widely fluctuated depending on the ordering time point or the presence of clinical intervention (e.g. transfusion, AT III therapy) which means DIC score can vary in the evaluation time point. For example, if a physician suspects of DIC in the early stage and calculates DIC score, it may present low score. Conversely, if the blood was taken in the severe terminal stage, it may present high score.
1) Do you have a correction plan for this bias in the meta-analysis?
2) Furthermore, will you include the laboratory findings only tested on the same day or will you set a specific inclusion period for laboratory results?
Thank you for your important comments and questions. Although we do not have a plan to adjust for clinical exposures to such factors as transfusion and anticoagulant therapy, we will define DIC criteria assessed at the earliest point in individual studies as the index test to minimize the influence of clinical exposures and patients in the severe terminal stage. According to the reviewer's comments, we have revised the following sentences in the Methods and Discussion sections.
(Lines 122-124)
In case DIC criteria are assessed more than once, the data evaluated at the earliest time point will be used as the index test.
(Lines 256-261)
Second, several interventions, such as transfusion and anticoagulant therapy, can affect coagulation parameters and, subsequently, the DIC score. As there may be no predefined protocol for diagnostic time points, we will use the data for assessment of DIC criteria that was evaluated at the earliest time point as the index test to minimize the influence of clinical exposure in this review.
3. The authors selected 6 DIC scoring systems (ISTH overt, non-overt, JMHW, JAAM, KSTH, and CDSS) to evaluate their prognostic value. However, one of the difficult things to compare DIC scoring systems is the lack of standardization for fibrin-related markers and their tests. An identical sample can present different values (e.g. report ranges, report units) for fibrin-related markers depending on the analysis principles or analyzers. This is why ISTH scoring systems use the term 'strong and moderate' increase for their criteria.
1) For pooling the data and comparison, how will the authors define the cut-off values for 'strong and moderate increase' or adjust their different cut-off values?
Reply
Thank you for your important comments and question. According to the reviewer's comments, we added the following sentence in the Methods section.
(Lines 124-126)
Cut-off values of fibrin-related markers, antithrombin, protein C, and thrombin-antithrombin complex in the ISTH overt/non-overt DIC criteria will be defined according to the individual studies.
2) Please provide more description for the analysis strategy in this heterogeneity of the laboratory tests.
Thank you for your important suggestion. Accordingly, we revised the following sentence in the Methods section.
(Lines 224-228)
4. Based on the raised questions above, DIC scoring systems include difficult characteristics for metaanalysis to compare their diagnostic or prognostic value. I wonder that making a conclusion which DIC criteria are superior for predicting mortality can lead to very dangerous and biased results. Although the attempt to provide a meta-analysis for the prognostic value of DIC scoring systems is a valuable work, the conclusion should not be biased and over-emphasized.
Reply
According to the reviewer's comments, we revised the following sentence in the Discussion section.
(Lines 265-267)
This meta-analysis will be the first report to reveal the characteristics of several DIC criteria for the prediction of mortality and may be useful in assessing overall populations of critically ill patients and sepsis patients.
Reply
PRISMA statement support is shown in the manuscript on lines 99-101. We also added the sentence below in the Funding section.
( This research received no specific grant from any funding agency in the public, commercial, or notfor-profit sectors.
Response to reviewer #2
Major comments
The etiology of DIC is different, sepsis, trauma, hematological malignancies, hepatic failure, etc. Different DIC scores were used to evaluate the different types of coagulation caused by different diseases. For example, JAAM score was generally used for sepsis.
Reply
Thank you for your important comments and suggestions. The variety of study populations can influence the heterogeneity of the predictive value of the DIC criteria. We often encounter cases in which several clinical conditions are involved in critical illness settings. Thus, we believe it is of great value for critical care physicians to evaluate the predictive value of the DIC criteria in the overall population of critically ill patients as well as in some specific populations such as those with sepsis or trauma. We will also perform subgroup analysis of trauma patients if sufficient numbers of studies are available, according to the reviewer's suggestions. Accordingly, we have revised the following sentence in the Methods section and added the following sentences as limitations in the Discussion section Meta-regression analysis and subgroup analysis will be performed using the following as covariates: sepsis or not, trauma or not, year of publication, country, prevalence of DIC (<50% or ≥50%), baseline mortality risk, sample size (<100 or ≥100), types of fibrin-related markers, and cut-off values of fibrinrelated markers.
(Lines 261-264)
Third, the variety of study populations can influence the heterogeneity of the predictive value of the DIC criteria. Thus, we will perform subgroup analyses focused on sepsis and trauma, which are the major causes of DIC in critically ill patients. 
GENERAL COMMENTS
The major concerns were revised properly, however, the minor concern still remain. In the PRISMA-P checklist table, reported page numbers for contributions and Support are presented as 'P17'. But, the information is presented in other pages. Please correct the page numbers.
